Dry Eye and MGD

86% OF PATIENTS WITH DRY EYE HAVE MGD

Research has determined that the leading cause of eye discomfort for over 86% of patients with dry eye is related to blockage of the tiny glands in our eyelids known as meibomian glands, and not necessarily due to a lack of tear production. When you blink, the glands release this essential oil that acts as the front line of protection for the tears, lubricating the surface of the eyes. When these glands become blocked, production of the necessary oils to protect the watery layer on the tear film is compromised thus causes this watery layer to evaporate and leave the eye surface exposed.

UNDERSTANDING MGD, THE LEADING CAUSE OF DRY EYE

A routine check for MGD as a part of any eye exam is recommended. MGD is progressive a disease but can be managed effectively if detected in its early stages. If left undetected, over time results can be long-term structural damage of the glands and even permanent gland loss. When MGD occurs, the protective oil that normally flows from the eyelid’s meibomian glands slows or stops.

LIPIFLOW, A PROVEN MGD TREATMENT

The clinical science behind MGD as the primary cause of dry eye and its treatment is supported by over 25 years of scientific research. Gland blockages can be removed to restore proper gland function and reduce the progression of MGD, provided your gland structure is healthy. LipiFlow is the only FDA cleared treatment that properly heats the inside and outside of the eyelids while providing a gentle massaging action to properly remove gland blockages. Most patients receiving treatment notice improvement with symptoms over time but may need regular treatment every 1-2 years. The treatment is virtually painless and takes less than 12 minutes.

IS IT DRY EYE OR MGD?